Although we cannot disregard the role of CDKN3 in tumor migration and invasion, the partial inhibition of CDKN3 expression (35–50%) suggests its involvement in tumor progression may be by inducing cell proliferation through a direct action on the cell cycle. The gene discussed is CDKN3; the disease is neoplasm.